US Patent 7476403 Oral extended-release composition
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Avinash Nangia0
Boyong Li0
Monte Browder0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+287 characters)
Article
Patent abstract
The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07476403 Oral extended-release composition US Patent 7476403 Oral extended-release composition
Infobox
Patent Number
074764030
Patent Number
74764030
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074764030
Date of Patent
January 13, 2009
0Patent Application Number
108694970
Date Filed
June 16, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07476403 Oral extended-release composition
Infobox
Is a
Patent jurisdiction
Patent number
07476403
Date of patent
January 13, 2009
Patent application number
10869497
Date Filed
June 16, 2004
Patent primary examiner
Find more entities like US Patent 7476403 Oral extended-release composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.